Stocktoria
INOVIO PHARMACEUTICALS, INC. INO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1998-12-08
INOVIO PHARMACEUTICALS, INC. statistics & valuation
Market cap$90.5M
P / B3.8×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -132871.3% | -51616.9% | -17300.3% | -2607.4% | -16972.3% |
| Net margin | -130000.0% | -49254.3% | -16239.9% | -2726.7% | -17109.9% |
| FCF margin | -136074.5% | -48019.1% | -14986.2% | -2116.3% | -12223.6% |
| Return on assets | -114.3% | -94.7% | -79.0% | -80.3% | -61.2% |
| Return on equity | -352.5% | -156.6% | -115.1% | -125.8% | -76.0% |
| Current ratio | 1.40 | 2.77 | 3.60 | 3.25 | 6.82 |
| Revenue growth | -70.0% | -73.8% | -91.9% | 478.2% | -76.1% |
Source: SEC EDGAR filings · CIK 0001055726 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.